System Transmission

Top Signal

100#1 JOB

Activity

2181Ripe

+940 today

System

Livenow

Terminal Asset View

stockNASDAQ

AUPH

$13.95-2.92%

Aurinia Pharmaceuticals Inc - Common Shares

Overripe

Official Site

Market value

24H Total Traded

Total supply

52-Week Range

Ripeness Index

43Overripe

Live Analysis Active

Company Mission

Aurinia Pharmaceuticals develops and sells a prescription medication called Lupkynis that treats lupus nephritis, which is an autoimmune kidney disease. Doctors prescribe this drug to patients whose immune systems attack their own kidneys, and the company makes money when patients fill their prescriptions through pharmacies and healthcare systems.

AUP

Industry Context

The biotech industry focuses on developing new medical treatments through scientific research. Companies in this space often have high research costs and face strict government approval processes for their drugs, which can lead to significant stock price swings based on clinical trial results or regulatory decisions.

Scoring Terminal

Intelligence Pipeline Active

Algorithm Verified

Asset Diagnostics

ProtocolV2.1_TACTICAL

Technical Matrix

Scanning

80Matrix

Market Momentum

49.6— Holding Steady

Trend Strength

25— Active Setup

Momentum Engine

Ready

Velocity Score

StaticOptimal FlowMax Vel

Trading Activity

0.8x— Normal Volume

Today's Change

-2.92%— Live Performance

Social Frequency

Listening

Social Freq

0.0x

Normal Vol

X/Twitter Activity

0.0x— Streaming

Reddit Buzz

0.0x— Synced

System Observation

ANALYSIS:Monitoring pattern stability. Currently scanning for high-confidence technical signals.

Lat14ms

BufOK

Positive Catalysts

No active score modifiers detected

Risk Flags

EMA Distance-0

Price is overextended from the 20-day trend lead.

52W Threshold-1

Price is extended significantly above 52-week highs.

Banana Farmer tracks 100's of signals to synthesize this proprietary score.

0Velocity

Awaiting Data

Social Intelligence Pulse.

Our engine is currently indexing AUPH across global social channels to detect early sentiment shifts and technical alignment.

XMonitoring

RedditMonitoring

WebMonitoring

Social GrowthPending

Signal CoverageInitializing

Signal Catalysts

Intelligence Narrative Connected

Updated 11:29 AM UTC

As-of 03-15-2026 11:13 UTC

Develops drugs that treat autoimmune diseases and makes money by selling these medications to hospitals and pharmacies.

Weekly price range is narrowing near recent levels, suggesting the stock is coiling tighter and may make a bigger move soon.

Biotech sector faces regulatory uncertainty, which can create volatility for drug developers like this one as they navigate approval processes.

Educational only. Not investment advice.

Precision Intelligence Model

Live Terminal Stream

Loading chart...